GB1543543A - Long acting preparation of cefalexin - Google Patents

Long acting preparation of cefalexin

Info

Publication number
GB1543543A
GB1543543A GB19853/77A GB1985377A GB1543543A GB 1543543 A GB1543543 A GB 1543543A GB 19853/77 A GB19853/77 A GB 19853/77A GB 1985377 A GB1985377 A GB 1985377A GB 1543543 A GB1543543 A GB 1543543A
Authority
GB
United Kingdom
Prior art keywords
cefalexin
long acting
acting preparation
preparation
long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB19853/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of GB1543543A publication Critical patent/GB1543543A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
GB19853/77A 1976-05-13 1977-05-11 Long acting preparation of cefalexin Expired GB1543543A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (1)

Publication Number Publication Date
GB1543543A true GB1543543A (en) 1979-04-04

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
GB19853/77A Expired GB1543543A (en) 1976-05-13 1977-05-11 Long acting preparation of cefalexin

Country Status (27)

Country Link
JP (1) JPS52139713A (enExample)
AR (1) AR224494A1 (enExample)
AT (1) AT351159B (enExample)
AU (1) AU508793B2 (enExample)
BE (1) BE854640A (enExample)
CA (1) CA1085296A (enExample)
CS (1) CS208196B2 (enExample)
DD (1) DD132232A5 (enExample)
DE (1) DE2721785A1 (enExample)
DK (1) DK208077A (enExample)
ES (1) ES458710A1 (enExample)
FI (1) FI771491A7 (enExample)
FR (1) FR2350836A1 (enExample)
GB (1) GB1543543A (enExample)
GR (1) GR68895B (enExample)
HU (1) HU184196B (enExample)
IE (1) IE45415B1 (enExample)
IL (1) IL52075A (enExample)
MX (1) MX5976E (enExample)
NL (1) NL7704879A (enExample)
NZ (1) NZ183927A (enExample)
PL (1) PL111183B1 (enExample)
PT (1) PT66514B (enExample)
RO (1) RO72935A (enExample)
SE (1) SE426780B (enExample)
SU (1) SU1218919A3 (enExample)
ZA (1) ZA772757B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141342A (en) * 1983-06-15 1984-12-19 Shionogi & Co Long-acting formulation of cefaclor
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
BRPI0608917A2 (pt) * 2005-04-12 2017-07-11 Elan Pharma Int Ltd Composição de liberação controlada de antibiótico, e, método para o tratamento de infecção bacteriana

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141342A (en) * 1983-06-15 1984-12-19 Shionogi & Co Long-acting formulation of cefaclor
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Also Published As

Publication number Publication date
PT66514A (en) 1977-06-01
IE45415B1 (en) 1982-08-25
JPS52139713A (en) 1977-11-21
RO72935A (ro) 1982-07-06
CS208196B2 (en) 1981-08-31
SU1218919A3 (ru) 1986-03-15
NZ183927A (en) 1980-02-21
IL52075A (en) 1980-06-30
CA1085296A (en) 1980-09-09
DK208077A (da) 1977-11-14
PT66514B (en) 1978-10-16
IL52075A0 (en) 1977-07-31
ZA772757B (en) 1978-04-26
AT351159B (de) 1979-07-10
PL111183B1 (en) 1980-08-30
JPS5547611B2 (enExample) 1980-12-01
AU2507877A (en) 1978-11-16
DD132232A5 (de) 1978-09-13
AR224494A1 (es) 1981-12-15
FI771491A7 (enExample) 1977-11-14
FR2350836B1 (enExample) 1981-02-06
ES458710A1 (es) 1978-03-01
NL7704879A (nl) 1977-11-15
SE426780B (sv) 1983-02-14
HU184196B (en) 1984-07-30
IE45415L (en) 1977-11-13
ATA341877A (de) 1978-12-15
PL198058A1 (pl) 1979-03-26
DE2721785C2 (enExample) 1989-03-16
BE854640A (fr) 1977-09-01
DE2721785A1 (de) 1977-11-24
GR68895B (enExample) 1982-03-15
FR2350836A1 (fr) 1977-12-09
MX5976E (es) 1984-09-12
AU508793B2 (en) 1980-04-03
SE7705502L (sv) 1977-11-14

Similar Documents

Publication Publication Date Title
JPS5344563A (en) Preparation of benzothiazolylsulfenamide
PT66146B (en) Preparation of meta-aryloxy-benzaldehydes
PH13874A (en) Preparation of 6-substituted-dihydropyrams
JPS5320411A (en) Improvement of preparation
NZ183927A (en) Long-acting cefalexin preparation
NZ183733A (en) Preparation of 1-n-substituted-kanamycins
JPS57115182A (en) Preparation of bacteriocine
ZA773566B (en) Preparation of gamma-pyrones
JPS52133978A (en) Preparation of 22aryllbenzoxazole or 22arylbenzthiazole
IL51806A (en) Preparation of alkylthiomethyl-phenols
JPS5328168A (en) Preparation of 11phenyll33aminopyrazole
JPS5313690A (en) Preparation of homoo or coopolymer of alphaamonoolefin
JPS5323937A (en) Preparation of paraaaminoarylamine or paraaalkylaminoarylamine
JPS5331795A (en) Preparation of polyoxyalkylenee polyesterrpolysulfiddpolythiol
JPS52116427A (en) Preparation of nitrobenzole
JPS52126491A (en) Preparation of polyyalphaaolefin
GB1541427A (en) Preparation of hydroxysulphobetaines
IL53038A (en) Preparation of certain nuclear-chlorinated benzotrichlorides
JPS5337666A (en) Preparation of monobenzylidenesorbitol
JPS52116463A (en) Preparation of 22oxoopyrrolidineennalkylamide
JPS5320412A (en) Improvement of preparation
JPS52142072A (en) Preparation of perfluoroo44oxoo2*55dimethyll 22fluorocarbonyll1*33dioxolan
NZ186106A (en) Preparation of haloacylamides
ZA773195B (en) Preparation of cyanoesters
JPS52144667A (en) Preparation of nnchlorophalimide

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee